FARALLON CAPITAL PARTNERS LP 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 12:11 pm Purchase |
2024-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FARALLON CAPITAL PARTNERS LP | 2,108,262 9.900% |
83,262 (+4.11%) |
Filing |
| 2024-01-26 09:11 am Purchase |
2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FARALLON CAPITAL PARTNERS LP | 2,025,000 9.600% |
475,000 (+30.65%) |
Filing |
| 2023-02-06 09:06 am Purchase |
2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
FARALLON CAPITAL PARTNERS LP | 1,550,000 7.500% |
1,550,000 (New Position) |
Filing |